πŸ—‚οΈ Navigation

AbCellera Biologics

The Antibody Discovery Engine.

Visit Website β†’

Overview

AbCellera has developed an AI-powered antibody discovery platform that searches and analyzes natural immune systems to find antibodies that can be developed into new drugs. Their full-stack, integrated platform enables the rapid discovery of a wide range of antibodies, including those for challenging targets. They partner with pharmaceutical and biotech companies to accelerate the development of new antibody therapies.

✨ Key Features

  • AI-powered antibody discovery
  • Single-cell analysis
  • High-throughput screening
  • Deep sequencing and bioinformatics
  • End-to-end antibody discovery

🎯 Key Differentiators

  • AI-powered, full-stack platform for antibody discovery.
  • Ability to screen millions of single B cells.
  • Rapid response capabilities for pandemics and emerging diseases.

Unique Value: Accelerates the discovery of novel antibody therapeutics by using AI to search and analyze natural immune systems at scale.

🎯 Use Cases (4)

Therapeutic antibody discovery Vaccine research Immuno-oncology Infectious disease research

βœ… Best For

  • Co-developed a COVID-19 antibody therapy that received Emergency Use Authorization.

πŸ’‘ Check With Vendor

Verify these considerations match your specific requirements:

  • Small molecule drug discovery

πŸ† Alternatives

Adimab Distributed Bio Ligand Pharmaceuticals

Offers a more comprehensive and rapid approach to antibody discovery compared to traditional hybridoma or phage display technologies.

πŸ’» Platforms

NA

πŸ”Œ Integrations

NA

πŸ›Ÿ Support Options

  • βœ“ Email Support
  • βœ“ Dedicated Support (NA tier)

πŸ’° Pricing

Contact for pricing

Free tier: NA

Visit AbCellera Biologics Website β†’